Phase I study of combination therapy with oral 9-nitrocamptothecin [rubitecan] and oral etoposide
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Etoposide; Rubitecan
- Indications Solid tumours
- Focus Adverse reactions
- 26 Sep 2012 Biomarkers information updated
- 09 May 2007 Updated from DMS 13 Feb 2007
- 20 Sep 2005 New trial record.